www.fdanews.com/articles/147376-rigel-astrazeneca-strike-potential-100-million-asthma-drug-deal

Rigel, AstraZeneca Strike Potential $100 Million Asthma Drug Deal

June 20, 2012

AstraZeneca will license an experimental asthma treatment from South San Francisco’s Rigel Pharmaceuticals in a potential $100 million deal, Rigel said.
San Francisco Business Journal